Search Results for: riken

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN

Masayo-Takahashi

In a surprise, Dr. Masayo Takahashi has announced that she has left RIKEN. Takahashi indicates she will be new President of a company called Vision Care, Inc. as part of the Kobe Eye Center. I’ve pasted a picture of Takahashi’s Tweet with translation more toward the bottom of the post. A big thanks to Piero …

Stem cell pioneer Masayo Takahashi (高橋 政代) leaves RIKEN Read More »

Perspectives on final RIKEN report on STAP cell scandal & what comes next

STAP-cells-FIgure

The Japanese research institute RIKEN has come full circle in a way on the STAP cell scandal. Note that the STAP papers included not only authors from RIKEN, but also from Brigham and Women’s Hospital/Harvard Medical School. With its final report released today (also a powerpoint of images were released including the one showing a …

Perspectives on final RIKEN report on STAP cell scandal & what comes next Read More »

RIKEN fails to reproduce STAP, big CDB shake up expected

STAP-stem-cells

Nikkei is reporting that the RIKEN internal attempt to replicate so-called STAP (acid bath) cells has failed. Update: apparently, although RIKEN calls the efforts preliminary, the team tried to make STAP an amazing 22 times and 22 times it failed. The rumors for weeks in the stem cell gapevine that RIKEN itself could not get …

RIKEN fails to reproduce STAP, big CDB shake up expected Read More »

Don’t Penalize All of RIKEN CDB for STAP Cell Flap

RIKEN-CDB

As the STAP cell fiasco has evolved, there has been discussion of various possible resolutions or even penalties for those involved, both institutions like RIKEN and individuals. One of the most extreme and I believe way out of proportion potential outcomes suggested has been the dismantling of RIKEN’s entire Center for Developmental Biology (CDB) in …

Don’t Penalize All of RIKEN CDB for STAP Cell Flap Read More »

RIKEN rejects Obokata appeal on alleged STAP cell misconduct

Obokata-press-conference

A RIKEN committee has rejected an appeal by Dr. Haruko Obokata regarding its finding of research misconduct related to two papers in Nature claiming the production of so-called STAP cells and STAP stem cells. Earlier the committee had ruled that Obokata had allegedly engaged in misconduct and that there problems with the research. Obokata appealed …

RIKEN rejects Obokata appeal on alleged STAP cell misconduct Read More »

RIKEN Report Is Virtual Acid Bath of Criticism for Obokata

si-Haruko

RIKEN Institute in Japan has formally announced the complete findings of its investigation into the STAP cell research,  Haruko Obokata, and Nature papers. RIKEN almost entirely blamed Obokata for the STAP mess in this report and they didn’t mince words. The RIKEN report alleged that Obokata had engaged in two instances of “research misconduct” as …

RIKEN Report Is Virtual Acid Bath of Criticism for Obokata Read More »

RIKEN Initial PR Reaction to STAP Cell Fiasco

STAP-stem-cells

The controversial STAP stem cell papers published in Nature had authors both from RIKEN in Japan and Brigham and Women’s Hospital/Harvard. What is the RIKEN interim take on the STAP cell situation? We’ve had pretty much silence from Harvard itself on this matter publicly. Dr. Charles Vacanti, senior author on one of the STAP papers, …

RIKEN Initial PR Reaction to STAP Cell Fiasco Read More »

Reactions to RIKEN’s STAP cell protocol

STAP-from-T-cells

A small group of the STAP authors via RIKEN have now released a detailed protocol also available at Nature Protocol Exchange for making STAP stem cells entitled “Essential technical tips for STAP cell conversion culture from somatic cells”. This comes about 5 weeks after publication of their Nature STAP stem cell papers. 2020 update: With the 4th and …

Reactions to RIKEN’s STAP cell protocol Read More »

Japan conditionally approves new IPS cell-based heart study

Yoshiki-Sawa-IPS-cells-stem-cells-heart-diseease

Where do things stand with IPS cell translational research? The newest development is that regulators in Japan just have given conditional approval to an Osaka University team to an induced pluripotent stem (IPS) cell-based study for ischemic heart disease. For years IPS cell-based products have been on-again off-again in active clinical study for macular degeneration, work …

Japan conditionally approves new IPS cell-based heart study Read More »

Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives

Takahashi-IPS-transplant

A team of researchers at RIKEN and Kobe City Medical Center reported at a press conference today a serious adverse event in a clinical trial participant receiving an induced pluripotent stem cell (IPS cell)-based therapy for vision loss. According to Japan Times and Yahoo! Japan (in Japanese), the patient in question in the IPS cell …

Adverse event in IPS cell (ips細胞) trial for vision loss in Japan: initial perspectives Read More »